Validations: Extensions, Changes & Re-verification
Cleaning Agent or CIP Change: Hold-Time Consequences Understanding the implications of cleaning agent or Clean-In-Place (CIP) changes related to hold-time studies is paramount in pharmaceutical operations. This detailed tutorial examines the necessary steps for valid and compliant hold-time assessments focusing on equipment, bulk, and intermediate holds, while adhering to regulatory expectations such as 21 CFR Part 211 and Annex 15….
Equipment Modifications: Dead-Legs, Ports, and Valves Equipment Modifications: Dead-Legs, Ports, and Valves This guide provides a comprehensive step-by-step approach for pharmaceutical professionals focused on the validation of equipment modifications. The aim is to maintain compliance with regulatory requirements while understanding equipment hold times, microbial limits, and the associated sampling plans necessary for ensuring product quality and safety. This tutorial highlights…
Supplier Changes: Letters of Guarantee and Bridging Supplier Changes: Letters of Guarantee and Bridging In the pharmaceutical industry, maintaining compliance with regulatory expectations is paramount to ensuring product quality and safety. One of the critical factors in maintaining compliance involves understanding the nuances of equipment hold time, especially when changes occur within the supplier environment. This comprehensive guide aims to…
Scale-Up: Extending Hold-Time Across Volumes Scale-Up: Extending Hold-Time Across Volumes Pharmaceutical manufacturing processes often utilize hold times to ensure the integrity and quality of the product throughout various steps of production. This article provides a detailed guide on extending hold times across different volumes, addressing the implications on equipment and product safety within compliance frameworks such as 21 CFR Part…
Extending Hold-Time: What Evidence Is Enough In the pharmaceutical manufacturing environment, understanding and controlling hold times for equipment and bulk materials is crucial. This step-by-step guide is intended for pharmaceutical professionals engaged in validation activities, providing insights into extending hold times, sampling plans, acceptance criteria, and trending data to ensure compliance with the US FDA, EMA, MHRA, and PIC/S standards….